P2D Bioscience
Manufacturing · Ohio, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2180 E Galbraith Rd Bldg D Rm 124, Cinci...Phone Number
(513) 475-6618Website
www.p2dinc.comRevenue
<$5 MillionIndustry
About P2D Bioscience
P2D Bioscience is a specialty pharmaceutical company dedicated to developing innovative drugs for central nervous system inflammatory disorders, including Frontotemporal Dementia and Alzheimer's disease. The company employs Targeted Phenotypic Screening and transgenic preclinical models to expedite drug development. P2D's pipeline includes orally active isoindoline TNFα inhibitors for FTD and AD, as well as benztropine-analog DAT inhibitors for ADHD. Their aim is to advance drug candidates through preclinical and early clinical studies before seeking partners for further development and commercialization.Explore more
P2D Bioscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to P2D Bioscience
Compare insights from companies similar to P2D Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
P2D Bioscience Tech Stack
A closer look at the technologies used by P2D Bioscience
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding P2D Bioscience
Sign Up For FreeTo access detailed company insights
P2D Bioscience is a specialty pharmaceutical company dedicated to developing innovative drugs for central nervous system inflammatory disorders, including Frontotemporal Dementia and Alzheimer's disease. The company employs Targeted Phenotypic Screening and transgenic preclinical models to expedite drug development. P2D's pipeline includes orally a... Read More
